<html lang="en">

  <head>
    <title>miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic
      tumors in localized clear cell renal carcinoma</title>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <link href="https://unpkg.com/@stencila/thema@2/dist/themes/stencila/styles.css"
      rel="stylesheet">
    <script src="https://unpkg.com/@stencila/thema@2/dist/themes/stencila/index.js"
      type="text/javascript"></script>
    <script
      src="https://unpkg.com/@stencila/components@&lt;=1/dist/stencila-components/stencila-components.esm.js"
      type="module"></script>
    <script
      src="https://unpkg.com/@stencila/components@&lt;=1/dist/stencila-components/stencila-components.js"
      type="text/javascript" nomodule=""></script>
  </head>

  <body>
    <main role="main">
      <article itemscope="" itemtype="http://schema.org/Article" data-itemscope="root">
        <h1 itemprop="headline"
          content="miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized cle…">
          miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic
          tumors in localized clear cell renal carcinoma</h1>
        <meta itemprop="image"
          content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=miRNA%20profiling%20in%20renal%20carcinoma%20suggest%20the%20existence%20of%20a%20group%20of%20pro-angionenic%20tumors%20in%20localized%20cle%E2%80%A6">
        <ol data-itemprop="authors">
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Lucía Trilla-Fuertes"><span
              data-itemprop="givenNames"><span itemprop="givenName">Lucía</span></span><span
              data-itemprop="familyNames"><span
                itemprop="familyName">Trilla-Fuertes</span></span><span
              data-itemprop="affiliations"><a itemprop="affiliation"
                href="#author-organization-1">1</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Natalia Miranda"><span data-itemprop="givenNames"><span
                itemprop="givenName">Natalia</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Miranda</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-2">2</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Daniel Castellano"><span data-itemprop="givenNames"><span
                itemprop="givenName">Daniel</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Castellano</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-3">3</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Rocío López-Vacas"><span data-itemprop="givenNames"><span
                itemprop="givenName">Rocío</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">López-Vacas</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-4">4</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Carlos A. Farfán Tello"><span
              data-itemprop="givenNames"><span itemprop="givenName">Carlos</span><span
                itemprop="givenName">A.</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Farfán</span><span
                itemprop="familyName">Tello</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-3">3</a><a itemprop="affiliation"
                href="#author-organization-5">5</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Guillermo de Velasco"><span
              data-itemprop="givenNames"><span itemprop="givenName">Guillermo</span></span><span
              data-itemprop="familyNames"><span itemprop="familyName">de</span><span
                itemprop="familyName">Velasco</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-3">3</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Felipe Villacampa"><span data-itemprop="givenNames"><span
                itemprop="givenName">Felipe</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Villacampa</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-6">6</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Elena López-Camacho"><span
              data-itemprop="givenNames"><span itemprop="givenName">Elena</span></span><span
              data-itemprop="familyNames"><span
                itemprop="familyName">López-Camacho</span></span><span
              data-itemprop="affiliations"><a itemprop="affiliation"
                href="#author-organization-1">1</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Guillermo Prado-Vázquez"><span
              data-itemprop="givenNames"><span itemprop="givenName">Guillermo</span></span><span
              data-itemprop="familyNames"><span
                itemprop="familyName">Prado-Vázquez</span></span><span
              data-itemprop="affiliations"><a itemprop="affiliation"
                href="#author-organization-1">1</a><a itemprop="affiliation"
                href="#author-organization-4">4</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Andrea Zapater-Moros"><span
              data-itemprop="givenNames"><span itemprop="givenName">Andrea</span></span><span
              data-itemprop="familyNames"><span
                itemprop="familyName">Zapater-Moros</span></span><span
              data-itemprop="affiliations"><a itemprop="affiliation"
                href="#author-organization-1">1</a><a itemprop="affiliation"
                href="#author-organization-4">4</a><a itemprop="affiliation"
                href="#author-organization-7">7</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Enrique Espinosa"><span data-itemprop="givenNames"><span
                itemprop="givenName">Enrique</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Espinosa</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-7">7</a><a itemprop="affiliation"
                href="#author-organization-8">8</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Juan Ángel Fresno Vara"><span
              data-itemprop="givenNames"><span itemprop="givenName">Juan</span><span
                itemprop="givenName">Ángel</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Fresno</span><span
                itemprop="familyName">Vara</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-1">1</a><a itemprop="affiliation"
                href="#author-organization-4">4</a><a itemprop="affiliation"
                href="#author-organization-7">7</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Álvaro Pinto"><span data-itemprop="givenNames"><span
                itemprop="givenName">Álvaro</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Pinto</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-8">8</a></span>
          </li>
          <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
            <meta itemprop="name" content="Angelo Gámez-Pozo"><span data-itemprop="givenNames"><span
                itemprop="givenName">Angelo</span></span><span data-itemprop="familyNames"><span
                itemprop="familyName">Gámez-Pozo</span></span><span data-itemprop="affiliations"><a
                itemprop="affiliation" href="#author-organization-1">1</a><a itemprop="affiliation"
                href="#author-organization-4">4</a></span>
          </li>
        </ol>
        <ol data-itemprop="affiliations">
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-1"
            id="author-organization-1"><span itemprop="name">Biomedica Molecular Medicine SL,
              Madrid, Spain</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-2"
            id="author-organization-2"><span itemprop="name">Urology Service, Hospital Universitario
              12 de Octubre, Madrid, Spain</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-3"
            id="author-organization-3"><span itemprop="name">Medical Oncology Service, Hospital
              Universitario 12 de Octubre, Madrid, Spain</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-4"
            id="author-organization-4"><span itemprop="name">Molecular Oncology and Pathology Lab,
              Hospital Universitario La Paz-IdiPAZ, Madrid, Spain</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-5"
            id="author-organization-5"><span itemprop="name">Clínica Internacional S.A., Lima,
              Perú</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-6"
            id="author-organization-6"><span itemprop="name">Urology Department, Clínica Universidad
              de Navarra, Madrid, Spain</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-7"
            id="author-organization-7"><span itemprop="name">Biomedical Research Networking Center
              on Oncology-CIBERONC, ISCIII, Madrid, Spain</span></li>
          <li itemscope="" itemtype="http://schema.org/Organization" itemid="#author-organization-8"
            id="author-organization-8"><span itemprop="name">Medical Oncology Service, La Paz
              University Hospital-IdiPAZ, Madrid, Spain</span></li>
        </ol><span itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
          <meta itemprop="name" content="Unknown"><span itemscope=""
            itemtype="http://schema.org/ImageObject" itemprop="logo">
            <meta itemprop="url"
              content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
          </span>
        </span><time itemprop="datePublished" datetime="2020-02-28">2020-02-28</time>
        <ul data-itemprop="about">
          <li itemscope="" itemtype="http://schema.org/DefinedTerm" itemprop="about"><span
              itemprop="name">Research Article</span></li>
        </ul>
        <ul data-itemprop="identifiers">
          <li itemscope="" itemtype="http://schema.org/PropertyValue" itemprop="identifier">
            <meta itemprop="propertyID" content="https://registry.identifiers.org/registry/doi">
            <span itemprop="name">doi</span><span
              itemprop="value">10.1371/journal.pone.0229075</span>
          </li>
          <li itemscope="" itemtype="http://schema.org/PropertyValue" itemprop="identifier">
            <meta itemprop="propertyID"
              content="https://registry.identifiers.org/registry/publisher-id"><span
              itemprop="name">publisher-id</span><span itemprop="value">PONE-D-19-33682</span>
          </li>
          <li itemscope="" itemtype="http://schema.org/PropertyValue" itemprop="identifier">
            <meta itemprop="propertyID"
              content="https://registry.identifiers.org/registry/elocation-id"><span
              itemprop="name">elocation-id</span><span itemprop="value">e0229075</span>
          </li>
        </ul>
        <section data-itemprop="description">
          <h2 data-itemtype="http://schema.stenci.la/Heading">Abstract</h2>
          <meta itemprop="description"
            content="Renal cell carcinoma comprises a variety of entities, the most common being the clear-cell, papillary and chromophobe subtypes. These subtypes are related to different clinical evolution; however, most therapies have been developed for clear-cell carcinoma and there is not a specific treatment based on different subtypes. In this study, one hundred and sixty-four paraffin samples from primary nephrectomies for localized tumors were analyzed. MiRNAs were isolated and measured by microRNA arrays. Significance Analysis of Microarrays and Consensus Cluster algorithm were used to characterize different renal subtypes. The analyses showed that chromophobe renal tumors are a homogeneous group characterized by an overexpression of miR 1229, miR 10a, miR 182, miR 1208, miR 222, miR 221, miR 891b, miR 629-5p and miR 221-5p. On the other hand, clear cell renal carcinomas presented two different groups inside this histological subtype, with differences in miRNAs that regulate focal adhesion, transcription, apoptosis and angiogenesis processes. Specifically, one of the defined groups had an overexpression of proangiogenic microRNAs miR185, miR126 and miR130a. In conclusion, differences in miRNA expression profiles between histological renal subtypes were established. In addition, clear cell renal carcinomas had different expression of proangiogenic miRNAs. With the emergence of antiangiogenic drugs, these differences could be used as therapeutic targets in the future or as a selection method for tailoring personalized treatments.">
          <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Renal cell carcinoma
            comprises a variety of entities, the most common being the clear-cell, papillary and
            chromophobe subtypes. These subtypes are related to different clinical evolution;
            however, most therapies have been developed for clear-cell carcinoma and there is not a
            specific treatment based on different subtypes. In this study, one hundred and
            sixty-four paraffin samples from primary nephrectomies for localized tumors were
            analyzed. MiRNAs were isolated and measured by microRNA arrays. Significance Analysis of
            Microarrays and Consensus Cluster algorithm were used to characterize different renal
            subtypes. The analyses showed that chromophobe renal tumors are a homogeneous group
            characterized by an overexpression of miR 1229, miR 10a, miR 182, miR 1208, miR 222, miR
            221, miR 891b, miR 629-5p and miR 221-5p. On the other hand, clear cell renal carcinomas
            presented two different groups inside this histological subtype, with differences in
            miRNAs that regulate focal adhesion, transcription, apoptosis and angiogenesis
            processes. Specifically, one of the defined groups had an overexpression of
            proangiogenic microRNAs miR185, miR126 and miR130a. In conclusion, differences in miRNA
            expression profiles between histological renal subtypes were established. In addition,
            clear cell renal carcinomas had different expression of proangiogenic miRNAs. With the
            emergence of antiangiogenic drugs, these differences could be used as therapeutic
            targets in the future or as a selection method for tailoring personalized treatments.
          </p>
        </section>
        <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec001">Introduction</h2>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Renal carcinoma (RC) is the
          sixth most common cancer in men and the eight in women, with 73,820 estimated new cases
          and 14,770 estimated deaths in the United States in 2019 <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref001"><span
                data-itemtype="http://schema.org/Boolean">true</span></a></cite>. Two thirds of
          patients have localized disease and an additional 16% have locoregional disease (stage
          III) at diagnosis. A significant proportion of all these patients (up to 40% in stage III)
          will eventually relapse <span itemscope=""
            itemtype="http://schema.stenci.la/CiteGroup"><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref002"><span
                  data-itemtype="http://schema.org/Number">2</span></a></cite><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref003"><span
                  data-itemtype="http://schema.org/Number">3</span></a></cite></span>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Antiangiogenic multi-kinase
          inhibitors have demonstrated significant efficacy in the metastatic setting, but have not
          fulfilled expectations in the adjuvant setting. Sorafenib (SORCE trial), pazopanib
          (PROTECT trial) and axitinib (ATLAS trial) failed to improve disease-free survival when
          compared with placebo, whereas sunitinib improved disease-free survival but did not impact
          in overall survival (STRAC trial) [<cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref004"><span
                data-itemtype="http://schema.org/Number">4</span></a></cite>–<cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref007"><span
                data-itemtype="http://schema.org/Number">7</span></a></cite>]. As a consequence,
          sunitinib has been approved for adjuvant therapy by the Food and Drug Administration, but
          not by the European Medicines Agency and observation remains the standard of care after
          resection.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The current classical
          classification of renal carcinoma refers to subtypes that have been named on the basis of
          predominant cytoplasmic or architectural features, anatomic location, correlation with a
          specific disease background, as well as molecular alterations or familial syndromes <cite
            itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref008"><span
                data-itemtype="http://schema.org/Number">8</span></a></cite>. The Cancer Genome
          Atlas has made considerable efforts to molecularly characterized different neoplasms,
          amongst them, renal carcinoma, establishing molecular characteristics of the different
          histological renal subtypes <span itemscope=""
            itemtype="http://schema.stenci.la/CiteGroup"><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref009"><span
                  data-itemtype="http://schema.org/Number">9</span></a></cite><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref010"><span
                  data-itemtype="http://schema.org/Number">10</span></a></cite></span>. So far, this
          information has not contributed to improve the personalized treatment for patients with
          renal cell carcinoma.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Molecular markers different
          from gene expression could improve our understanding of this disease. MicroRNAs are small
          RNA sequences which regulate different cellular processes, such as cellular proliferation,
          apoptosis or stem cell differentiation <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref011"><span
                data-itemtype="http://schema.org/Number">11</span></a></cite>. They are good
          molecular biomarkers or even therapeutic targets, especially in clinical paraffin samples,
          because of their stability. <cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref012"><span
                data-itemtype="http://schema.org/Number">12</span></a></cite>. For these reasons,
          miRNAs may have acquired importance as biomarkers in cancer. There are several studies in
          which microRNAs have been related to chemotherapy resistant or to cancer prognosis and
          detection <span itemscope="" itemtype="http://schema.stenci.la/CiteGroup"><cite
              itemscope="" itemtype="http://schema.stenci.la/Cite"><a
                href="#pone-0229075-ref013"><span
                  data-itemtype="http://schema.org/Number">13</span></a></cite><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref014"><span
                  data-itemtype="http://schema.org/Number">14</span></a></cite></span>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">The aim of this study is to
          determine miRNA profiles which allow us to characterize RC subtypes. Interestingly, we
          identified two groups of clear cell renal carcinoma (ccRCC) tumors, one of them with an
          overexpression of pro-angiogenic microRNAs.</p>
        <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec002">Material and methods
        </h2>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec003">Samples</h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">One hundred and sixty-four
          patients diagnosed with localized RC were recruited for this study. An observational study
          was carried out, where all radical and partial nephrectomies performed at Hospital
          Universitario 12 de Octubre in Madrid between 1999 and 2008 were included. Written
          informed consent was obtained from all patients. The protocol was approved by the Ethical
          Committee of Hospital Universitario 12 de Octubre. The evolution of these patients was
          obtained from clinical records.</p>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec004">miRNA isolation and
          quantification</h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">396 miRNAs were measured from
          164 renal formalin-fixed paraffin-embedded (FFPE) tumor samples. microRNA extraction and
          sample processing were done as previously described <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref015"><span
                data-itemtype="http://schema.org/Number">15</span></a></cite>. Briefly, selected
          FFPE tumor specimens were cut into serial sections with a thickness of 10 μm. Total RNA
          was then isolated using the miRNEasy Kit (Quiagen). Purified RNA quality control for
          quantity and purity was assessed using an ND-1000 NanoDrop spectrophotometer (Thermo
          Fisher Scientific).</p>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec005">MicroRNA arrays</h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">MicroRNA arrays experiments
          were done as previously described <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref016"><span
                data-itemtype="http://schema.org/Number">16</span></a></cite>. Briefly, samples were
          hybridized to Human miRNA Microarray Release 14.0, 8x15K (Agilent Technologies). MicroRNA
          Labeling Kit (Agilent Technologies) was used to label RNA. 100 ng of total RNA were
          dephosphorylated and Cyanine 3-pCp molecule was ligated to the 3´ end of each RNA molecule
          by using T4 RNA ligase. One hundred ng of Cy3 labeled RNA were hybridized for 20 hours at
          55°C in a hybridization oven (G2545A, Agilent) set to 20 rpm in a final concentration of
          1X GE Blocking Agent and 1X Hi-RPM Hybridization Buffer, according to manufacturer&#39;s
          instructions (miRNA Microarray System Protocol, Agilent Technologies). Arrays were washed
          according to manufacturer&#39;s instructions (miRNA Microarray System Protocol, Agilent
          Technologies), dried out using a centrifuge at 1000 rpm for 2 min and scanned at 5μm
          resolution on an Agilent DNA Microarray Scanner (G2565BA, Agilent Technologies) equipped
          with extended dynamic range (XDR) software. Images provided by the scanner were analyzed
          using Agilent´s software Feature Extraction version 10.7.3.1. Data were quantile
          normalized as previously described <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref017"><span
                data-itemtype="http://schema.org/Number">17</span></a></cite>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Only miRNAs with an average
          intensity over the 20th percentile of the overall intensities and a detectable signal in
          at least 10 percent of the hybridized samples considered for further analysis. Batch
          effect was corrected using ComBat software <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref018"><span
                data-itemtype="http://schema.org/Number">18</span></a></cite>. Data is available in
          Gene Expression Omnibus Database under the identifier GSE144082.</p>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec006">Consensus cluster
        </h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Consensus cluster using R
          v3.2.5 and <em itemscope=""
            itemtype="http://schema.stenci.la/Emphasis">ConsensusClusterPlus</em> package was
          performed to establish subgroups <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref019"><span
                data-itemtype="http://schema.org/Number">19</span></a></cite>. Consensus cluster
          allows the determination of the optimum number of groups based on the similarity between
          expression profiles. Then, differential miRNAs expression patterns among groups was
          analyzed by Significance Analysis of Microarrays (SAM) with MeV 4.9 <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref020"><span
                data-itemtype="http://schema.org/Number">20</span></a></cite>. SAM performed a
          t-test correcting over permutations of the number of samples <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref021"><span
                data-itemtype="http://schema.org/Number">21</span></a></cite>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Targets of these differential
          miRNAs were searched in miRwalk database <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref022"><span
                data-itemtype="http://schema.org/Number">22</span></a></cite>. This information was
          used to perform a gene ontology analysis and to establish relationship with biological
          functions. Gene ontology analyses were done using Enrichr webtool developed by Ma’ayan lab
          <cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref023"><span
                data-itemtype="http://schema.org/Number">23</span></a></cite>.</p>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec007">Statistical analyses
        </h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Statistical analyses were done
          using GraphPad Prism v6. All p-values were two-sided and considered statistically
          significant under 0.05. For survival analyses between the two groups defined in ccRCC
          patients, a log-rank test was used to compare the two obtained curves. Additionally,
          contingency analyses (Chi-squared tests) were used to establish the independence between
          clinical data and the new ccRCC classification. For comparisons of angiogenic microRNA
          expression between the two ccRCC groups, non-parametric Mann- Whitney tests were used.</p>
        <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec008">Results</h2>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec009">Patient cohort</h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">164 renal tumor samples were
          studied. One hundred of these samples corresponded to clear-cell carcinomas (ccRCC), 16 to
          papillary tumors, and 21 chromophobe tumors. Subtype information was not available for 27
          tumors. Of these 164 samples, clinical data were available for 142 patients. Twenty-three
          percent of the patients suffered a relapse and the median of follow-up was 54 months. The
          median overall survival was 57 months. Clinical characteristics of these patients were
          summarized in <a href="#pone-0229075-t001" itemscope=""
            itemtype="http://schema.stenci.la/Link">Table 1</a>.</p>
        <table id="pone-0229075-t001" itemscope="" itemtype="http://schema.org/Table">
          <caption><label data-itemprop="label">Table 1</label>
            <div itemprop="caption">
              <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
                id="patient-characteristics">Patient characteristics.</h4>
            </div>
          </caption>
          <thead>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <th itemscope="" itemtype="http://schema.stenci.la/TableCell"></th>
              <th itemscope="" itemtype="http://schema.stenci.la/TableCell">Number of patients</th>
              <th itemscope="" itemtype="http://schema.stenci.la/TableCell">Percentage</th>
            </tr>
          </thead>
          <tbody>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Number of patients</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">142</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">100%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Age (median)</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">34–83 (66)</td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Gender</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Male</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">85</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">60%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Female</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">57</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">40%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">ECOG-Karnofsky</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">90–100</td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">106</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">74.6%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">70–90</td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">31</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">21.8%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">50–70</td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">4</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">2.9%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">30–40</td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Boolean">true</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">0.7%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Furhman grade</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.stenci.la/Null">null</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Boolean">true</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">0.7%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Boolean">true</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">7</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">5%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">2</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">74</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">52%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">3</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">38</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">27%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">4</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">7</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">5%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">Unknown</td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">15</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">10.3%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Tumor size</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">T1</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">97</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">69%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">T2</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">19</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">13%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">T3</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">26</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">18%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Nodal stage</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">N0</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">131</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">92.3%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">N1</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">5</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">3.5%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">N2</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">6</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">4.2%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Nephrectomy</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"></td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Radical</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">116</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">82%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Partial</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">23</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">16%</td>
            </tr>
            <tr itemscope="" itemtype="http://schema.stenci.la/TableRow">
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><strong itemscope=""
                  itemtype="http://schema.stenci.la/Strong">Unknown</strong></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell"><span
                  data-itemtype="http://schema.org/Number">3</span></td>
              <td itemscope="" itemtype="http://schema.stenci.la/TableCell">2%</td>
            </tr>
          </tbody>
        </table>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec010">Characterization of
          differences between histological subtypes</h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">A SAM was done to characterize
          different miRNA expression patterns between histological groups. It was not possible to
          find differential miRNAs between papillary and the two other histological subtypes. SAM
          showed that chromophobe tumors are a very homogeneous molecular group with a higher
          expression of miR 1229, miR 10a, miR 182, miR 1208, miR 222, miR 221, miR 891b, miR 629-5p
          and miR 221-5p (<a href="#pone-0229075-g001" itemscope=""
            itemtype="http://schema.stenci.la/Link">Fig 1</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g001"
          title="Fig 1"><label data-itemprop="label">Fig 1</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
              id="sam-of-chromophobe-subtype-against-the-rest-of-tumors">SAM of chromophobe subtype
              against the rest of tumors.</h4>
            <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">ccRCC = Clear cell renal
              carcinoma.</p>
          </figcaption>
        </figure>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">On the other hand, ccRCC tumors
          were split into two different groups in the SAM graph, suggesting the existence of two
          molecular groups in ccRCC according the miRNA expression (<a href="#pone-0229075-g002"
            itemscope="" itemtype="http://schema.stenci.la/Link">Fig 2</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g002"
          title="Fig 2"><label data-itemprop="label">Fig 2</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
              id="sam-of-ccrcc-tumors-against-the-rest-of-them">SAM of ccRCC tumors against the rest
              of them.</h4>
            <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">ccRCC = Clear cell renal
              carcinoma.</p>
          </figcaption>
        </figure>
        <h3 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec011">ccRCC groups’
          characterization</h3>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">With the aim of establishing
          these possible subgroups in ccRCC, a consensus cluster was done. Consensus cluster grouped
          patients by the similarity in their expression patterns and it allows the definition of
          the optimum number of groups, showing that two different molecular patient groups existed
          in ccRCC: ccRCC1 (44 patients) and ccRCC2 (56 patients) (<a href="#pone-0229075-g003"
            itemscope="" itemtype="http://schema.stenci.la/Link">Fig 3</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g003"
          title="Fig 3"><label data-itemprop="label">Fig 3</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <p itemscope="" itemtype="http://schema.stenci.la/Paragraph"><strong itemscope=""
                itemtype="http://schema.stenci.la/Strong">A.</strong> Delta graph suggested two
              groups as the optimum number of groups in these subtype. <strong itemscope=""
                itemtype="http://schema.stenci.la/Strong">B.</strong> Tracking plot showed different
              sample classifications making different number of groups.</p>
          </figcaption>
        </figure>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Contingency analyses showed
          that this new ccRCC classification was independent from clinical data, such as tumor size
          or nodal status; i.e, there are no differences in tumor size or nodal status between these
          two groups (p = 0.55 and p = 0.39 respectively). However, ccRCC2 tumors had a lower
          Furhman grade than ccRCC1 tumors (p = 0.04).</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Moreover, a SAM established 136
          differentially expressed miRNAs between these two groups (<a href="#pone-0229075-g004"
            itemscope="" itemtype="http://schema.stenci.la/Link">Fig 4</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g004"
          title="Fig 4"><label data-itemprop="label">Fig 4</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
              id="sam-between-two-ccrcc-identified-groups">SAM between two ccRCC identified groups.
            </h4>
          </figcaption>
        </figure>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Experimentally validated
          targets of these 136 miRNAs were determined using miRwalk database, and a gene ontology
          analysis of these genes was performed afterwards. This analysis showed that these genes
          were mainly related with focal adhesion, transcription, apoptosis and angiogenesis
          processes (<a href="#pone-0229075-g005" itemscope=""
            itemtype="http://schema.stenci.la/Link">Fig 5</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g005"
          title="Fig 5"><label data-itemprop="label">Fig 5</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
              id="gene-ontology-of-gene-targets-of-the-136-differential-mirnas">Gene ontology of
              gene targets of the 136 differential miRNAs.</h4>
          </figcaption>
        </figure>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Additionally, the two subgroups
          of ccRCC were associated with a different survival, although not statistically significant
          (<a href="#pone-0229075-g006" itemscope="" itemtype="http://schema.stenci.la/Link">Fig
            6</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g006"
          title="Fig 6"><label data-itemprop="label">Fig 6</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <h4 itemscope="" itemtype="http://schema.stenci.la/Heading"
              id="survival-curves-of-the-two-ccrcc-groups-defined-by-consensus-cluster">Survival
              curves of the two ccRCC groups defined by Consensus cluster.</h4>
            <p itemscope="" itemtype="http://schema.stenci.la/Paragraph"><strong itemscope=""
                itemtype="http://schema.stenci.la/Strong">A.</strong> Distant-relapse free survival
              curves of the two ccRCC groups. <strong itemscope=""
                itemtype="http://schema.stenci.la/Strong">B.</strong> Overall survival curves of the
              two ccRCC groups.</p>
          </figcaption>
        </figure>
        <h4 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec012">New ccRCC groups had
          differential expression of miRNAs involved in angiogenesis</h4>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Interestingly, the two ccRCC
          subgroups presented differences in expression of some miRNAs previously associated with
          angiogenesis. In general, ccRCC2 had more expression of miR185, miR126 and miR130a, all of
          them proangiogenic miRNAs (<a href="#pone-0229075-g007" itemscope=""
            itemtype="http://schema.stenci.la/Link">Fig 7</a>).</p>
        <figure itemscope="" itemtype="http://schema.stenci.la/Figure" id="pone-0229075-g007"
          title="Fig 7"><label data-itemprop="label">Fig 7</label><img src="" alt="" itemscope=""
            itemtype="http://schema.org/ImageObject">
          <figcaption>
            <h5 itemscope="" itemtype="http://schema.stenci.la/Heading"
              id="mirnas-related-with-angiogenesis-differentialy-expressed-between-two-ccrcc-groups">
              miRNAs related with angiogenesis differentialy expressed between two ccRCC groups.
            </h5>
          </figcaption>
        </figure>
        <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec013">Discussion</h2>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Renal-cell carcinoma comprises
          several histological subgroups <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref008"><span
                data-itemtype="http://schema.org/Number">8</span></a></cite>. The Cancer Genome
          Atlas analyzed these histological subtypes and characterized molecular differences between
          them <span itemscope="" itemtype="http://schema.stenci.la/CiteGroup"><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref009"><span
                  data-itemtype="http://schema.org/Number">9</span></a></cite><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref010"><span
                  data-itemtype="http://schema.org/Number">10</span></a></cite></span>. However, all
          these advances have not been translated into clinical applications yet. For this reason,
          further insight into the molecular biology of these tumors is still needed.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">There are previous
          classifications of renal histological subtypes based on miRNA signatures, although a
          reduce number of miRNAs were used in these analyses [<cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref024"><span
                data-itemtype="http://schema.org/Number">24</span></a></cite>–<cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref026"><span
                data-itemtype="http://schema.org/Number">26</span></a></cite>]. In this study, 396
          miRNAs were analyzed in 164 RC FFPE samples by microRNA arrays. The main advantage of the
          measurement of miRNAs is that they are more stable than longer RNAs or DNA in paraffin
          samples <cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref012"><span
                data-itemtype="http://schema.org/Number">12</span></a></cite>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">SAM showed differences at the
          miRNA expression level in chromophobe and ccRCC, but no in papillary tumors. The fact that
          it was not possible to define differential miRNAs in the papillary subgroup could be due
          to the reduced number of this type of tumors in our cohort and the intrinsic heterogeneity
          of this group.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">miR10-a, miR222, and miR221
          have been previously described as overexpressed in chromophobe subtype, what agrees with
          our results <span itemscope="" itemtype="http://schema.stenci.la/CiteGroup"><cite
              itemscope="" itemtype="http://schema.stenci.la/Cite"><a
                href="#pone-0229075-ref025"><span
                  data-itemtype="http://schema.org/Number">25</span></a></cite><cite itemscope=""
              itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref026"><span
                  data-itemtype="http://schema.org/Number">26</span></a></cite></span>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Regarding ccRCC tumors,
          differential expression pattern analysis suggested the existence of two different groups
          inside this histological subtype. This was confirmed by Consensus Cluster, which defined
          two groups with different expression in miRNAs whose established targets are related to
          angiogenesis, apoptosis, transcription and focal adhesion.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Interestingly, three of the
          miRNAs (miR185, miR126, and miR130a) differentially expressed between our two ccRCC groups
          have been previously related with pro-angiogenesis processes.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Expression levels of miR185
          have been correlated with tumor size, Fuhrman grade, and TNM staging. The overexpression
          of this miRNA inhibited proliferation and induced apoptosis <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref027"><span
                data-itemtype="http://schema.org/Number">27</span></a></cite>. Moreover, elevated
          miR185 levels were associated with high vascular endothelial growth factor receptor 2
          (VEGFR) expression and therefore a pro-angiogenic activity in ccRCC <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref028"><span
                data-itemtype="http://schema.org/Number">28</span></a></cite>.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">On the other hand, miR126
          inhibits the expression of vascular cell adhesion molecule 1 (VCAM1) implicated in
          leukocyte adherence to endothelial cells <cite itemscope=""
            itemtype="http://schema.stenci.la/Cite"><a href="#pone-0229075-ref029"><span
                data-itemtype="http://schema.org/Number">29</span></a></cite>. This miRNA has a
          pro-angiogenic function <cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref030"><span
                data-itemtype="http://schema.org/Number">30</span></a></cite>. It is downregulated
          in metastatic ccRCC versus primary tumors. Its overexpression is negatively correlated
          with tumor size and is associated with longer distant relapse-free survival and overall
          survival. miR126 overexpression is also related with a reduction in cellular proliferation
          <cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref031"><span
                data-itemtype="http://schema.org/Number">31</span></a></cite>. According to these
          facts, miR126 was underexpressed in our ccRCC1 group which had a worst prognosis.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">miR130a were identified as
          proangiogenic miRNA due to its inhibitory effect in the anti-angiogenic homeobox GAX and
          HoxA5 <cite itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref032"><span
                data-itemtype="http://schema.org/Number">32</span></a></cite>. A relationship
          between this miRNA and renal carcinoma had not been previously described.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">Considering the controversial
          efficacy of antiangiogenic drugs in the adjuvant setting of renal-cell carcinoma <cite
            itemscope="" itemtype="http://schema.stenci.la/Cite"><a
              href="#pone-0229075-ref033"><span
                data-itemtype="http://schema.org/Number">33</span></a></cite>, defining a
          proangiogenic group may be important to select patients more likely to benefit from these
          treatments. In the future, a class predictor could be developed to define this
          pro-angiogenic group. Such a predictor should be validated in an independent cohort.</p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">In this work, we have
          characterized differences between RC histological subtypes using miRNAs and have defined
          two ccRCC groups with different expression of pro-angiogenic miRNAs. Differences between
          subtypes could be used as therapeutic targets or as a method to select patients for
          personalized treatments in the future.</p>
        <h2 itemscope="" itemtype="http://schema.stenci.la/Heading" id="sec014">Supporting
          information</h2>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">
        <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
            itemtype="http://schema.org/Organization" itemprop="publisher">
            <meta itemprop="name" content="Unknown"><span itemscope=""
              itemtype="http://schema.org/ImageObject" itemprop="logo">
              <meta itemprop="url"
                content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span>
          </span>
          <ol data-itemprop="authors"></ol>
          <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
            id="mirnas-measured-in-164-renal-carcinoma-paraffin-samples">miRNAs measured in 164
            renal carcinoma paraffin samples.</h3>
          <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TXT)</p>
        </div>
        </p>
        <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">
        <div itemscope="" itemtype="http://schema.org/MediaObject"><span itemscope=""
            itemtype="http://schema.org/Organization" itemprop="publisher">
            <meta itemprop="name" content="Unknown"><span itemscope=""
              itemtype="http://schema.org/ImageObject" itemprop="logo">
              <meta itemprop="url"
                content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
            </span>
          </span>
          <ol data-itemprop="authors"></ol>
          <h3 itemscope="" itemtype="http://schema.stenci.la/Heading"
            id="136-differential-mirnas-between-ccrcc-groups">136 differential miRNAs between ccRCC
            groups.</h3>
          <p itemscope="" itemtype="http://schema.stenci.la/Paragraph">(TXT)</p>
        </div>
        </p>
        <section data-itemprop="references">
          <h2 data-itemtype="http://schema.stenci.la/Heading">References</h2>
          <ol>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref001">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RL Siegel"><span data-itemprop="givenNames"><span
                      itemprop="givenName">RL</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Siegel</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="KD Miller"><span data-itemprop="givenNames"><span
                      itemprop="givenName">KD</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Miller</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Jemal"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Jemal</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2019">2019</time><span
                itemprop="headline">Cancer statistics, 2019</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">1</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">69</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">CA Cancer J Clin</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">7</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">34</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Cancer%20statistics,%202019">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref002">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="NK Janzen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">NK</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Janzen</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="HL Kim"><span data-itemprop="givenNames"><span
                      itemprop="givenName">HL</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kim</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RA Figlin"><span data-itemprop="givenNames"><span
                      itemprop="givenName">RA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Figlin</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="AS Belldegrun"><span
                    data-itemprop="givenNames"><span itemprop="givenName">AS</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Belldegrun</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2003">2003</time><span
                itemprop="headline"
                content="Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurr…">Surveillance
                after radical or partial nephrectomy for localized renal cell carcinoma and
                management of recurrent disease</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">4</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">30</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Urol Clin North Am</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">843</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">52</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Surveillance%20after%20radical%20or%20partial%20nephrectomy%20for%20localized%20renal%20cell%20carcinoma%20and%20management%20of%20recurr%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref003">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="T Janowitz"><span data-itemprop="givenNames"><span
                      itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Janowitz</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="SJ Welsh"><span data-itemprop="givenNames"><span
                      itemprop="givenName">SJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Welsh</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="K Zaki"><span data-itemprop="givenNames"><span
                      itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Zaki</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P Mulders"><span data-itemprop="givenNames"><span
                      itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Mulders</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="T Eisen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Eisen</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2013">2013</time><span
                itemprop="headline">Adjuvant therapy in renal cell carcinoma-past, present, and
                future</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">4</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">40</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Semin Oncol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">482</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">91</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Adjuvant%20therapy%20in%20renal%20cell%20carcinoma-past,%20present,%20and%20future">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref004">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Staehler"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Staehler</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RJ Motzer"><span data-itemprop="givenNames"><span
                      itemprop="givenName">RJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Motzer</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="DJ George"><span data-itemprop="givenNames"><span
                      itemprop="givenName">DJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">George</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="HS Pandha"><span data-itemprop="givenNames"><span
                      itemprop="givenName">HS</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Pandha</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="F Donskov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Donskov</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="B Escudier"><span data-itemprop="givenNames"><span
                      itemprop="givenName">B</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Escudier</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2018">2018</time><span
                itemprop="headline"
                content="Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-r…">Adjuvant
                sunitinib in patients with high-risk renal cell carcinoma: safety, therapy
                management, and patient-reported outcomes in the S-TRAC trial</span><span
                itemscope="" itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">10</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">29</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Ann Oncol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">2098</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">104</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Adjuvant%20sunitinib%20in%20patients%20with%20high-risk%20renal%20cell%20carcinoma:%20safety,%20therapy%20management,%20and%20patient-r%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref005">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="NJ Lawrence"><span data-itemprop="givenNames"><span
                      itemprop="givenName">NJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lawrence</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Martin"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Martin</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="ID Davis"><span data-itemprop="givenNames"><span
                      itemprop="givenName">ID</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Davis</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Troon"><span data-itemprop="givenNames"><span
                      itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Troon</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Sengupta"><span data-itemprop="givenNames"><span
                      itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Sengupta</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="E Hovey"><span data-itemprop="givenNames"><span
                      itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Hovey</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2018">2018</time><span
                itemprop="headline"
                content="What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or H…">What
                Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection
                of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators'
                Preferences in the SORCE Trial</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">2</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">2</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Kidney Cancer</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">123</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">31</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=What%20Survival%20Benefits%20are%20Needed%20to%20Make%20Adjuvant%20Sorafenib%20Worthwhile%20After%20Resection%20of%20Intermediate-%20or%20H%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref006">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RJ Motzer"><span data-itemprop="givenNames"><span
                      itemprop="givenName">RJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Motzer</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="NB Haas"><span data-itemprop="givenNames"><span
                      itemprop="givenName">NB</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Haas</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="F Donskov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Donskov</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Gross-Goupil"><span
                    data-itemprop="givenNames"><span itemprop="givenName">M</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Gross-Goupil</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Varlamov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Varlamov</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="E Kopyltsov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kopyltsov</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2017">2017</time><span
                itemprop="headline"
                content="Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized …">Randomized
                Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients
                With Localized or Locally Advanced Renal Cell Carcinoma</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">35</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">35</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">J Clin Oncol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">3916</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">23</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Randomized%20Phase%20III%20Trial%20of%20Adjuvant%20Pazopanib%20Versus%20Placebo%20After%20Nephrectomy%20in%20Patients%20With%20Localized%20%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref007">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Gross-Goupil"><span
                    data-itemprop="givenNames"><span itemprop="givenName">M</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Gross-Goupil</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="TG Kwon"><span data-itemprop="givenNames"><span
                      itemprop="givenName">TG</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kwon</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Eto"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Eto</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="D Ye"><span data-itemprop="givenNames"><span
                      itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ye</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Miyake"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Miyake</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="SI Seo"><span data-itemprop="givenNames"><span
                      itemprop="givenName">SI</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Seo</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2018">2018</time><span
                itemprop="headline"
                content="Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomi…">Axitinib
                versus placebo as an adjuvant treatment of renal cell carcinoma: results from the
                phase III, randomized ATLAS trial</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">12</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">29</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Ann Oncol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">2371</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">8</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Axitinib%20versus%20placebo%20as%20an%20adjuvant%20treatment%20of%20renal%20cell%20carcinoma:%20results%20from%20the%20phase%20III,%20randomi%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref008">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Moch"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Moch</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="AL Cubilla"><span data-itemprop="givenNames"><span
                      itemprop="givenName">AL</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Cubilla</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="PA Humphrey"><span data-itemprop="givenNames"><span
                      itemprop="givenName">PA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Humphrey</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="VE Reuter"><span data-itemprop="givenNames"><span
                      itemprop="givenName">VE</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Reuter</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="TM Ulbright"><span data-itemprop="givenNames"><span
                      itemprop="givenName">TM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ulbright</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2016">2016</time><span
                itemprop="headline"
                content="The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, a…">The
                2016 WHO Classification of Tumours of the Urinary System and Male Genital
                Organs-Part A: Renal, Penile, and Testicular Tumours</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">1</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">70</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Eur Urol</span></span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">93</span><span itemprop="pageEnd"
                data-itemtype="http://schema.org/Number">105</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=The%202016%20WHO%20Classification%20of%20Tumours%20of%20the%20Urinary%20System%20and%20Male%20Genital%20Organs-Part%20A:%20Renal,%20Penile,%20a%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref009">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="CJ Ricketts"><span data-itemprop="givenNames"><span
                      itemprop="givenName">CJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ricketts</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="AA De Cubas"><span data-itemprop="givenNames"><span
                      itemprop="givenName">AA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">De</span><span itemprop="familyName">Cubas</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Fan"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Fan</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="CC Smith"><span data-itemprop="givenNames"><span
                      itemprop="givenName">CC</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Smith</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Lang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lang</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="E Reznik"><span data-itemprop="givenNames"><span
                      itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Reznik</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2018">2018</time><span
                itemprop="headline">The Cancer Genome Atlas Comprehensive Molecular Characterization
                of Renal Cell Carcinoma</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">1</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">23</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Cell Rep</span></span></span></span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=The%20Cancer%20Genome%20Atlas%20Comprehensive%20Molecular%20Characterization%20of%20Renal%20Cell%20Carcinoma">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref010">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="WM Linehan"><span data-itemprop="givenNames"><span
                      itemprop="givenName">WM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Linehan</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="PT Spellman"><span data-itemprop="givenNames"><span
                      itemprop="givenName">PT</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Spellman</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="CJ Ricketts"><span data-itemprop="givenNames"><span
                      itemprop="givenName">CJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ricketts</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="CJ Creighton"><span
                    data-itemprop="givenNames"><span itemprop="givenName">CJ</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Creighton</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="SS Fei"><span data-itemprop="givenNames"><span
                      itemprop="givenName">SS</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Fei</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="C Davis"><span data-itemprop="givenNames"><span
                      itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Davis</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2016">2016</time><span
                itemprop="headline">Comprehensive Molecular Characterization of Papillary Renal-Cell
                Carcinoma</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">2</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">374</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">N Engl J Med</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">135</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">45</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Comprehensive%20Molecular%20Characterization%20of%20Papillary%20Renal-Cell%20Carcinoma">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref011">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="WT Wang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">WT</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Wang</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="YQ Chen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">YQ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Chen</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2014">2014</time><span
                itemprop="headline">Circulating miRNAs in cancer: from detection to
                therapy</span><span itemscope="" itemtype="http://schema.org/PublicationVolume"
                itemprop="isPartOf"><span itemprop="volumeNumber"
                  data-itemtype="http://schema.org/Number">7</span><span itemscope=""
                  itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                    itemprop="name">J Hematol Oncol</span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">86</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Circulating%20miRNAs%20in%20cancer:%20from%20detection%20to%20therapy">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref012">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Y Kakimoto"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kakimoto</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Tanaka"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Tanaka</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Kamiguchi"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kamiguchi</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="E Ochiai"><span data-itemprop="givenNames"><span
                      itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ochiai</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Osawa"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Osawa</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2016">2016</time><span
                itemprop="headline">MicroRNA Stability in FFPE Tissue Samples: Dependence on GC
                Content</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">9</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">11</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">PLoS One</span></span></span></span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=MicroRNA%20Stability%20in%20FFPE%20Tissue%20Samples:%20Dependence%20on%20GC%20Content">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref013">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="W Si"><span data-itemprop="givenNames"><span
                      itemprop="givenName">W</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Si</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J Shen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Shen</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Zheng"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Zheng</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="W Fan"><span data-itemprop="givenNames"><span
                      itemprop="givenName">W</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Fan</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2019">2019</time><span
                itemprop="headline">The role and mechanisms of action of microRNAs in cancer drug
                resistance</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">1</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">11</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Clin Epigenetics</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">25</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=The%20role%20and%20mechanisms%20of%20action%20of%20microRNAs%20in%20cancer%20drug%20resistance">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref014">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="YS Lee"><span data-itemprop="givenNames"><span
                      itemprop="givenName">YS</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lee</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Dutta"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Dutta</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2009">2009</time><span
                itemprop="headline">MicroRNAs in cancer</span><span itemscope=""
                itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                  itemprop="volumeNumber" data-itemtype="http://schema.org/Number">4</span><span
                  itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                    itemprop="name">Annu Rev Pathol</span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">199</span><span itemprop="pageEnd"
                data-itemtype="http://schema.org/Number">227</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=MicroRNAs%20in%20cancer">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref015">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Gámez-Pozo"><span
                    data-itemprop="givenNames"><span itemprop="givenName">A</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Gámez-Pozo</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J Berges-Soria"><span
                    data-itemprop="givenNames"><span itemprop="givenName">J</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Berges-Soria</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="JM Arevalillo"><span
                    data-itemprop="givenNames"><span itemprop="givenName">JM</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Arevalillo</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P Nanni"><span data-itemprop="givenNames"><span
                      itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Nanni</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="R López-Vacas"><span
                    data-itemprop="givenNames"><span itemprop="givenName">R</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">López-Vacas</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Navarro"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Navarro</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2015">2015</time><span
                itemprop="headline"
                content="Combined label-free quantitative proteomics and microRNA expression analysis of breast cancer unravel molecul…">Combined
                label-free quantitative proteomics and microRNA expression analysis of breast cancer
                unravel molecular differences with clinical implications</span><span itemscope=""
                itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                  itemprop="name">Cancer Res</span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">2243</span><span itemprop="pageEnd"
                data-itemtype="http://schema.org/Number">53</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Combined%20label-free%20quantitative%20proteomics%20and%20microRNA%20expression%20analysis%20of%20breast%20cancer%20unravel%20molecul%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref016">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Gámez-Pozo"><span
                    data-itemprop="givenNames"><span itemprop="givenName">A</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Gámez-Pozo</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="LM Antón-Aparicio"><span
                    data-itemprop="givenNames"><span itemprop="givenName">LM</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Antón-Aparicio</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="C Bayona"><span data-itemprop="givenNames"><span
                      itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Bayona</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P Borrega"><span data-itemprop="givenNames"><span
                      itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Borrega</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="MI Gallegos Sancho"><span
                    data-itemprop="givenNames"><span itemprop="givenName">MI</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Gallegos</span><span
                      itemprop="familyName">Sancho</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="R García-Domínguez"><span
                    data-itemprop="givenNames"><span itemprop="givenName">R</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">García-Domínguez</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2012">2012</time><span
                itemprop="headline"
                content="MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in adva…">MicroRNA
                expression profiling of peripheral blood samples predicts resistance to first-line
                sunitinib in advanced renal cell carcinoma patients</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">12</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">14</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Neoplasia</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">1144</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">52</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=MicroRNA%20expression%20profiling%20of%20peripheral%20blood%20samples%20predicts%20resistance%20to%20first-line%20sunitinib%20in%20adva%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref017">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P López-Romero"><span
                    data-itemprop="givenNames"><span itemprop="givenName">P</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">López-Romero</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="MA González"><span data-itemprop="givenNames"><span
                      itemprop="givenName">MA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">González</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Callejas"><span data-itemprop="givenNames"><span
                      itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Callejas</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Dopazo"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Dopazo</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RA Irizarry"><span data-itemprop="givenNames"><span
                      itemprop="givenName">RA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Irizarry</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2010">2010</time><span
                itemprop="headline">Processing of Agilent microRNA array data</span><span
                itemscope="" itemtype="http://schema.org/PublicationVolume"
                itemprop="isPartOf"><span itemprop="volumeNumber"
                  data-itemtype="http://schema.org/Number">3</span><span itemscope=""
                  itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                    itemprop="name">BMC Res Notes</span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">18</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Processing%20of%20Agilent%20microRNA%20array%20data">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref018">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="WE Johnson"><span data-itemprop="givenNames"><span
                      itemprop="givenName">WE</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Johnson</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="C Li"><span data-itemprop="givenNames"><span
                      itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Li</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Rabinovic"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Rabinovic</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2007">2007</time><span
                itemprop="headline">Adjusting batch effects in microarray expression data using
                empirical Bayes methods</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">1</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">8</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Biostatistics</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">118</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">27</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Adjusting%20batch%20effects%20in%20microarray%20expression%20data%20using%20empirical%20Bayes%20methods">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref019">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Monti"><span data-itemprop="givenNames"><span
                      itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Monti</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P Tamayo"><span data-itemprop="givenNames"><span
                      itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Tamayo</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J Mesirov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Mesirov</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="T Golub"><span data-itemprop="givenNames"><span
                      itemprop="givenName">T</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Golub</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2003">2003</time><span
                itemprop="headline"
                content="Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Micr…">Consensus
                Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene
                Expression Microarray Data</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">1</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">52</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Machine learning</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">91</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">118</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Consensus%20Clustering:%20A%20Resampling-Based%20Method%20for%20Class%20Discovery%20and%20Visualization%20of%20Gene%20Expression%20Micr%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref020">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="AI Saeed"><span data-itemprop="givenNames"><span
                      itemprop="givenName">AI</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Saeed</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="V Sharov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">V</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Sharov</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J White"><span data-itemprop="givenNames"><span
                      itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">White</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J Li"><span data-itemprop="givenNames"><span
                      itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Li</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="W Liang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">W</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Liang</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="N Bhagabati"><span data-itemprop="givenNames"><span
                      itemprop="givenName">N</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Bhagabati</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2003">2003</time><span
                itemprop="headline">TM4: a free, open-source system for microarray data management
                and analysis</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">2</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">34</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Biotechniques</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">374</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">8</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=TM4:%20a%20free,%20open-source%20system%20for%20microarray%20data%20management%20and%20analysis">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref021">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="VG Tusher"><span data-itemprop="givenNames"><span
                      itemprop="givenName">VG</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Tusher</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="R Tibshirani"><span
                    data-itemprop="givenNames"><span itemprop="givenName">R</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Tibshirani</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="G Chu"><span data-itemprop="givenNames"><span
                      itemprop="givenName">G</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Chu</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2001">2001</time><span
                itemprop="headline">Significance analysis of microarrays applied to the ionizing
                radiation response</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">9</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">98</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Proc Natl Acad Sci U S A</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">5116</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">21</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Significance%20analysis%20of%20microarrays%20applied%20to%20the%20ionizing%20radiation%20response">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref022">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Dweep"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Dweep</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="C Sticht"><span data-itemprop="givenNames"><span
                      itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Sticht</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P Pandey"><span data-itemprop="givenNames"><span
                      itemprop="givenName">P</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Pandey</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="N Gretz"><span data-itemprop="givenNames"><span
                      itemprop="givenName">N</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Gretz</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2011">2011</time><span
                itemprop="headline">miRWalk—database: prediction of possible miRNA binding sites by
                "walking" the genes of three genomes</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">5</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">44</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">J Biomed Inform</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">839</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">47</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=miRWalk%E2%80%94database:%20prediction%20of%20possible%20miRNA%20binding%20sites%20by%20%22walking%22%20the%20genes%20of%20three%20genomes">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref023">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="EY Chen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">EY</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Chen</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="CM Tan"><span data-itemprop="givenNames"><span
                      itemprop="givenName">CM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Tan</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Y Kou"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kou</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Q Duan"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Q</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Duan</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Z Wang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Z</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Wang</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="GV Meirelles"><span
                    data-itemprop="givenNames"><span itemprop="givenName">GV</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Meirelles</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2013">2013</time><span
                itemprop="headline">Enrichr: interactive and collaborative HTML5 gene list
                enrichment analysis tool</span><span itemscope=""
                itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                  itemprop="volumeNumber" data-itemtype="http://schema.org/Number">14</span><span
                  itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                    itemprop="name">BMC Bioinformatics</span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">128</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Enrichr:%20interactive%20and%20collaborative%20HTML5%20gene%20list%20enrichment%20analysis%20tool">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref024">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RM Silva-Santos"><span
                    data-itemprop="givenNames"><span itemprop="givenName">RM</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Silva-Santos</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="P Costa-Pinheiro"><span
                    data-itemprop="givenNames"><span itemprop="givenName">P</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Costa-Pinheiro</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Luis"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Luis</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="L Antunes"><span data-itemprop="givenNames"><span
                      itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Antunes</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="F Lobo"><span data-itemprop="givenNames"><span
                      itemprop="givenName">F</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lobo</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J Oliveira"><span data-itemprop="givenNames"><span
                      itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Oliveira</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2013">2013</time><span
                itemprop="headline">MicroRNA profile: a promising ancillary tool for accurate renal
                cell tumour diagnosis</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">10</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">109</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Br J Cancer</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">2646</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">53</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=MicroRNA%20profile:%20a%20promising%20ancillary%20tool%20for%20accurate%20renal%20cell%20tumour%20diagnosis">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref025">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="YM Youssef"><span data-itemprop="givenNames"><span
                      itemprop="givenName">YM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Youssef</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="NM White"><span data-itemprop="givenNames"><span
                      itemprop="givenName">NM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">White</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="J Grigull"><span data-itemprop="givenNames"><span
                      itemprop="givenName">J</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Grigull</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Krizova"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Krizova</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="C Samy"><span data-itemprop="givenNames"><span
                      itemprop="givenName">C</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Samy</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Mejia-Guerrero"><span
                    data-itemprop="givenNames"><span itemprop="givenName">S</span></span><span
                    data-itemprop="familyNames"><span
                      itemprop="familyName">Mejia-Guerrero</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2011">2011</time><span
                itemprop="headline">Accurate molecular classification of kidney cancer subtypes
                using microRNA signature</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">5</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">59</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Eur Urol</span></span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">721</span><span itemprop="pageEnd"
                data-itemtype="http://schema.org/Number">30</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Accurate%20molecular%20classification%20of%20kidney%20cancer%20subtypes%20using%20microRNA%20signature">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref026">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="MP Powers"><span data-itemprop="givenNames"><span
                      itemprop="givenName">MP</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Powers</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="K Alvarez"><span data-itemprop="givenNames"><span
                      itemprop="givenName">K</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Alvarez</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="HJ Kim"><span data-itemprop="givenNames"><span
                      itemprop="givenName">HJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kim</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="FA Monzon"><span data-itemprop="givenNames"><span
                      itemprop="givenName">FA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Monzon</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2011">2011</time><span
                itemprop="headline">Molecular classification of adult renal epithelial neoplasms
                using microRNA expression and virtual karyotyping</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">2</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">20</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Diagn Mol Pathol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">63</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">70</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Molecular%20classification%20of%20adult%20renal%20epithelial%20neoplasms%20using%20microRNA%20expression%20and%20virtual%20karyotyping">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref027">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="X Ma"><span data-itemprop="givenNames"><span
                      itemprop="givenName">X</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ma</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="D Shen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">D</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Shen</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="H Li"><span data-itemprop="givenNames"><span
                      itemprop="givenName">H</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Li</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Y Zhang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Zhang</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="X Lv"><span data-itemprop="givenNames"><span
                      itemprop="givenName">X</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lv</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Q Huang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Q</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Huang</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2015">2015</time><span
                itemprop="headline"
                content="MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel…">MicroRNA-185
                inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly
                in von Hippel-Lindau-inactivated clear cell renal cell carcinoma</span><span
                itemscope="" itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">4</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">33</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Urol Oncol</span></span></span></span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=MicroRNA-185%20inhibits%20cell%20proliferation%20and%20induces%20cell%20apoptosis%20by%20targeting%20VEGFA%20directly%20in%20von%20Hippel%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref028">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="HX Yuan"><span data-itemprop="givenNames"><span
                      itemprop="givenName">HX</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Yuan</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="JP Zhang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">JP</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Zhang</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="WT Kong"><span data-itemprop="givenNames"><span
                      itemprop="givenName">WT</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Kong</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="YJ Liu"><span data-itemprop="givenNames"><span
                      itemprop="givenName">YJ</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Liu</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="ZM Lin"><span data-itemprop="givenNames"><span
                      itemprop="givenName">ZM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lin</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="WP Wang"><span data-itemprop="givenNames"><span
                      itemprop="givenName">WP</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Wang</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2014">2014</time><span
                itemprop="headline"
                content="Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels…">Elevated
                microRNA-185 is associated with high vascular endothelial growth factor receptor 2
                expression levels and high microvessel density in clear cell renal cell
                carcinoma</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">12</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">35</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Tumour Biol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">12757</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">63</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Elevated%20microRNA-185%20is%20associated%20with%20high%20vascular%20endothelial%20growth%20factor%20receptor%202%20expression%20levels%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref029">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="TA Harris"><span data-itemprop="givenNames"><span
                      itemprop="givenName">TA</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Harris</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Yamakuchi"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Yamakuchi</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="M Ferlito"><span data-itemprop="givenNames"><span
                      itemprop="givenName">M</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Ferlito</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="JT Mendell"><span data-itemprop="givenNames"><span
                      itemprop="givenName">JT</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Mendell</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="CJ Lowenstein"><span
                    data-itemprop="givenNames"><span itemprop="givenName">CJ</span></span><span
                    data-itemprop="familyNames"><span itemprop="familyName">Lowenstein</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2008">2008</time><span
                itemprop="headline">MicroRNA-126 regulates endothelial expression of vascular cell
                adhesion molecule 1</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">5</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">105</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Proc Natl Acad Sci U S A</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">1516</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">21</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=MicroRNA-126%20regulates%20endothelial%20expression%20of%20vascular%20cell%20adhesion%20molecule%201">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref030">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="JE Fish"><span data-itemprop="givenNames"><span
                      itemprop="givenName">JE</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Fish</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="MM Santoro"><span data-itemprop="givenNames"><span
                      itemprop="givenName">MM</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Santoro</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="SU Morton"><span data-itemprop="givenNames"><span
                      itemprop="givenName">SU</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Morton</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="S Yu"><span data-itemprop="givenNames"><span
                      itemprop="givenName">S</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Yu</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="RF Yeh"><span data-itemprop="givenNames"><span
                      itemprop="givenName">RF</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Yeh</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="JD Wythe"><span data-itemprop="givenNames"><span
                      itemprop="givenName">JD</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Wythe</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2008">2008</time><span
                itemprop="headline">miR-126 regulates angiogenic signaling and vascular
                integrity</span><span itemscope="" itemtype="http://schema.org/PublicationIssue"
                itemprop="isPartOf"><span itemprop="issueNumber"
                  data-itemtype="http://schema.org/Number">2</span><span itemscope=""
                  itemtype="http://schema.org/PublicationVolume" itemprop="isPartOf"><span
                    itemprop="volumeNumber" data-itemtype="http://schema.org/Number">15</span><span
                    itemscope="" itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Dev Cell</span></span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">272</span><span itemprop="pageEnd"
                data-itemtype="http://schema.org/Number">84</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=miR-126%20regulates%20angiogenic%20signaling%20and%20vascular%20integrity">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref031">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="HW Khella"><span data-itemprop="givenNames"><span
                      itemprop="givenName">HW</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Khella</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Scorilas"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Scorilas</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="R Mozes"><span data-itemprop="givenNames"><span
                      itemprop="givenName">R</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Mozes</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="L Mirham"><span data-itemprop="givenNames"><span
                      itemprop="givenName">L</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Mirham</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="E Lianidou"><span data-itemprop="givenNames"><span
                      itemprop="givenName">E</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Lianidou</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="SN Krylov"><span data-itemprop="givenNames"><span
                      itemprop="givenName">SN</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Krylov</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2015">2015</time><span
                itemprop="headline">Low expression of miR-126 is a prognostic marker for metastatic
                clear cell renal cell carcinoma</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">3</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">185</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Am J Pathol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">693</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">703</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Low%20expression%20of%20miR-126%20is%20a%20prognostic%20marker%20for%20metastatic%20clear%20cell%20renal%20cell%20carcinoma">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref032">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="Y Chen"><span data-itemprop="givenNames"><span
                      itemprop="givenName">Y</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Chen</span></span>
                </li>
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="DH Gorski"><span data-itemprop="givenNames"><span
                      itemprop="givenName">DH</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Gorski</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2008">2008</time><span
                itemprop="headline"
                content="Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GA…">Regulation
                of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic
                homeobox genes GAX and HOXA5</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">3</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">111</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Blood</span></span></span></span><span itemprop="pageStart"
                data-itemtype="http://schema.org/Number">1217</span><span itemprop="pageEnd"
                data-itemtype="http://schema.org/Number">26</span><span itemscope=""
                itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Regulation%20of%20angiogenesis%20through%20a%20microRNA%20(miR-130a)%20that%20down-regulates%20antiangiogenic%20homeobox%20genes%20GA%E2%80%A6">
            </li>
            <li itemscope="" itemtype="http://schema.org/Article" itemprop="citation"
              id="pone-0229075-ref033">
              <ol data-itemprop="authors">
                <li itemscope="" itemtype="http://schema.org/Person" itemprop="author">
                  <meta itemprop="name" content="A Bex"><span data-itemprop="givenNames"><span
                      itemprop="givenName">A</span></span><span data-itemprop="familyNames"><span
                      itemprop="familyName">Bex</span></span>
                </li>
              </ol><time itemprop="datePublished" datetime="2017">2017</time><span
                itemprop="headline">Adjuvant sunitinib in renal cell carcinoma: from evidence to
                recommendation</span><span itemscope=""
                itemtype="http://schema.org/PublicationIssue" itemprop="isPartOf"><span
                  itemprop="issueNumber" data-itemtype="http://schema.org/Number">4</span><span
                  itemscope="" itemtype="http://schema.org/PublicationVolume"
                  itemprop="isPartOf"><span itemprop="volumeNumber"
                    data-itemtype="http://schema.org/Number">28</span><span itemscope=""
                    itemtype="http://schema.org/Periodical" itemprop="isPartOf"><span
                      itemprop="name">Ann Oncol</span></span></span></span><span
                itemprop="pageStart" data-itemtype="http://schema.org/Number">682</span><span
                itemprop="pageEnd" data-itemtype="http://schema.org/Number">4</span><span
                itemscope="" itemtype="http://schema.org/Organization" itemprop="publisher">
                <meta itemprop="name" content="Unknown"><span itemscope=""
                  itemtype="http://schema.org/ImageObject" itemprop="logo">
                  <meta itemprop="url"
                    content="https://via.placeholder.com/600x60/dbdbdb/4a4a4a.png?text=Unknown">
                </span>
              </span>
              <meta itemprop="image"
                content="https://via.placeholder.com/1200x714/dbdbdb/4a4a4a.png?text=Adjuvant%20sunitinib%20in%20renal%20cell%20carcinoma:%20from%20evidence%20to%20recommendation">
            </li>
          </ol>
        </section>
      </article>
    </main>
  </body>

</html>